Pfizer (PFE) Enters Agreement for $5B Accelerated Share Repurchase
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Pfizer Commences $5 Billion Accelerated Share Repurchase
February 3, 2017 8:10 AM ESTAccelerated Share Repurchase Assumed in Pfizers 2017 Financial Guidance Issued on January 31, 2017
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that it has entered into an accelerated share repurchase agreement with Citibank N.A. (Citibank) to repurchase $5 billion of Pfizers common stock. This agreement is part of Pfizers existing share repurchase authorization.
Approximately 126 million of the shares to be repurchased under the transaction will be received by Pfizer on February 6, 2017. At settlement of the agreement, which is expected to occur during or prior to the... More
